Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 4Ototoxicity 1Neurocognitive Disorders 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Central Nervous System Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Cisplatin 4Biopsy 4selpercatinib 3larotrectinib 3Vincristine 3Carboplatin 3erdafitinib 2ensartinib 2Temozolomide 2Radiotherapy 2Methotrexate 2Cyclophosphamide 2Chemotherapy, Adjuvant 2ulixertinib 1tipifarnib 1tazemetostat 1palbociclib 1olaparib 1niraparib 1neratinib 1lenvatinib 1ivosidenib 1ibrutinib 1entrectinib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Central Nervous System Neoplasms × Mental Status and Dementia Tests × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡